Genome-wide association study of aspirin-exacerbated respiratory disease in a Korean population. (Q53352652)

13 May 2018

title

Genome-wide association study of aspirin-exacerbated respiratory disease in a Korean population. (English)

1 reference

13 May 2018

genome-wide association study

main subject

0 references

1 reference

1 reference

Charisse Flerida A Pasaje

5

1 reference

13 May 2018

author name string

Byung Lae Park

1

1 reference

13 May 2018

Tae-Hoon Kim

2

1 reference

13 May 2018

Jeong-Hyun Kim

3

1 reference

13 May 2018

Joon Seol Bae

4

1 reference

13 May 2018

Hyun Sub Cheong

6

1 reference

13 May 2018

Lyoung Hyo Kim

7

1 reference

13 May 2018

Jong-Sook Park

8

1 reference

13 May 2018

Ho Sung Lee

9

1 reference

13 May 2018

Myung-Sin Kim

10

1 reference

13 May 2018

Inseon S Choi

11

1 reference

13 May 2018

Byoung Whui Choi

12

1 reference

13 May 2018

Mi-Kyeong Kim

13

1 reference

13 May 2018

SeungWoo Shin

14

1 reference

13 May 2018

Hyoung Doo Shin

15

1 reference

13 May 2018

Choon Sik Park

16

1 reference

13 May 2018

publication date

21 November 2012

1 reference

13 May 2018

published in

Human Genetics

1 reference

13 May 2018

volume

132

1 reference

13 May 2018

issue

3

1 reference

13 May 2018

page(s)

313-321

1 reference

13 May 2018

describes a project that uses

genome-wide association study

1 reference

Functional promoter polymorphism in the TBX21 gene associated with aspirin-induced asthma

inferred from title

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00439-012-1247-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-012-1247-2

Haploview: analysis and visualization of LD and haplotype maps

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-012-1247-2

The importance of COX-2 inhibition for aspirin induced asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-012-1247-2

Diagnostic value of clinical parameters in the prediction of aspirin-exacerbated respiratory disease in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-012-1247-2

HLA association in aspirin-intolerant asthma: DPB1*0301 as a strong marker in a Korean population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-012-1247-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-012-1247-2

Complement components and IgE in patients with asthma and aspirin idiosyncrasy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-012-1247-2

Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-012-1247-2

Genome-wide association analysis identifies PDE4D as an asthma-susceptibility gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-012-1247-2

Polymorphisms in the prostaglandin E2 receptor subtype 2 gene confer susceptibility to aspirin-intolerant asthma: a candidate gene approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-012-1247-2

The human leucocyte antigen-DRB1*1302-DQB1*0609-DPB1*0201 haplotype may be a strong genetic marker for aspirin-induced urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-012-1247-2

Association of thromboxane A2 receptor gene polymorphism with the phenotype of acetyl salicylic acid-intolerant asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-012-1247-2

Association of TNF-alpha genetic polymorphism with HLA DPB1*0301

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-012-1247-2

CysLTR1 promoter polymorphism and requirement for leukotriene receptor antagonist in aspirin-intolerant asthma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-012-1247-2

Genome-wide and follow-up studies identify CEP68 gene variants associated with risk of aspirin-intolerant asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-012-1247-2

Complement C3a and C4a increased in plasma of patients with aspirin-induced asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-012-1247-2

Medium- to high-throughput SNP genotyping using VeraCode microbeads

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-012-1247-2

Aspirin challenge and desensitization for aspirin-exacerbated respiratory disease: a practice paper

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-012-1247-2

Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-012-1247-2

EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-012-1247-2

Association analysis of peroxisome proliferator-activated receptors gamma gene polymorphisms with asprin hypersensitivity in asthmatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-012-1247-2

The HLA-DPB1*0301 marker might predict the requirement for leukotriene receptor antagonist in patients with aspirin-intolerant asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-012-1247-2

Association analysis of cysteinyl-leukotriene receptor 2 (CYSLTR2) polymorphisms with aspirin intolerance in asthmatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-012-1247-2

Leukotriene C4 synthase polymorphism and aspirin-induced asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-012-1247-2

A New Statistical Method for Haplotype Reconstruction from Population Data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00439-012-1247-2

HLA-DP typing by amplified fragment length polymorphisms (AFLPs)

21 January 2018

1 reference

12 December 2020

Nomenclature for factors of the HLA system, 1989

1 reference

12 December 2020

NSAID-induced bronchospasm--a common and serious problem. A report from MEDSAFE, the New Zealand Medicines and Medical Devices Safety Authority

1 reference

12 December 2020

Aspirin-induced asthma and HLA-DRB1 and HLA-DPB1 genotypes

1 reference

12 December 2020

Association of angiotensin I-converting enzyme gene polymorphisms with aspirin intolerance in asthmatics

1 reference

12 December 2020

Associations of functional NLRP3 polymorphisms with susceptibility to food-induced anaphylaxis and aspirin-induced asthma

1 reference

12 December 2020

10.1007/S00439-012-1247-2

Identifiers

DOI

1 reference

13 May 2018

1 reference

13 May 2018